Bibliographic evaluation.The goal of this examine is to establish probably the most cited research on lumbar spondylolisthesis and report their affect in backbone discipline. Thomson Reuters Net of Science-Science Quotation Index Expanded was searched utilizing title-specific search “spondylolisthesis.”

 

All research printed in English language between 1900 and 2019 had been included with no restrictions. The highest 100 cited articles had been recognized utilizing “Occasions cited” arranging articles from excessive to low in accordance with quotation rely. Additional evaluation was made to acquire the next objects: article title, writer’s title and specialty, nation of origin, establishment, journal of publication, yr of publication, citations quantity, examine design.

 

The quotation rely of the highest 100 articles ranged from 68 to 589. All printed between 1932 and 2016. Amongst 20 journals, Backbone had the very best variety of articles (49), with quotation variety of 6155 out of 13 618. Second ranked was the Journal of Bone and Joint Surgical procedure with 15 articles and whole citations of 3023. With regard to the first writer’s specialty, orthopedic surgeons contributed to the vast majority of high 100 record with 82 articles, and neurosurgery was the second specialty with 11 articles.

 

The USA had produced greater than half of the record with 59 articles. England was the second nation with 7 articles. Surgical administration of degenerative lumbar spondylolisthesis was the most typical mentioned subject.This text identifies the highest 100 influential articles on lumbar spondylolisthesis and acknowledges an vital facet of data evolution served by main researchers as they guided right this moment’s scientific choice making in spondylolisthesis.

 

Anti-Galectin 1/Lgals1 Antibody
A00470-1	BosterBio	100ug/vial	EUR 334

Polyclonal Goat anti-GST α-form
GST-ANTI-1	Detroit R&D	50 uL	EUR 280

Recombinant Human Galectin-1 Protein
PROTP09382-1	BosterBio	50ug	EUR 317
Description: Lectins, of either plant or animal origin, are carbohydrate binding proteins that interact with glycoprotein and glycolipids on the surface of animal cells. The Galectins are lectins that recognize and interact with β-galactoside moieties. Galectin-1 is an animal lectin that has been shown to interact with CD3, CD4, and CD45. It induces apoptosis of activated T-cells and T-leukemia cell lines and inhibits the protein phosphatase activity of CD45. Recombinant human Galectin-1 is a 14.5 kDa protein containing 134 amino acid residues.

Anti-Galectin-3 Monoclonal Antibody
M00621-1	BosterBio	100ul	EUR 397
Description: Mouse Monoclonal Galectin-3 Antibody. Validated in IF, IHC, WB and tested in Human, Mouse, Rat.

anti-Galectin 1
YF-PA12945	Abfrontier	100 ug	EUR 403
Description: Rabbit polyclonal to Galectin 1

Rabbit Polyclonal antibody Anti-CRBN
Anti-CRBN	ImmunoStep	50 µg	EUR 349

Anti-Galectin 1 Antibody
A00470-2	BosterBio	100ug/vial	EUR 294

Anti-Galectin-1 antibody
STJ93201	St John's Laboratory	200 µl	EUR 197
Description: Rabbit polyclonal to Galectin-1.

Anti-Galectin-1 antibody
STJ98716	St John's Laboratory	200 µl	EUR 197
Description: Rabbit polyclonal to Galectin-1.

anti- Galectin-1 antibody
FNab03314	FN Test	100µg	EUR 505.25
Description: Antibody raised against Galectin-1

anti- Galectin-1 antibody
FNab03315	FN Test	100µg	EUR 548.75
Description: Antibody raised against Galectin-1

Anti-Galectin 1 (1A8)
YF-MA13984	Abfrontier	100 ug	EUR 363
Description: Mouse monoclonal to Galectin 1

Anti-Galectin-1 antibody
PAab03314	Lifescience Market	100 ug	EUR 355

Anti-Galectin 1/LGALS1 Antibody
PA1422	BosterBio	100ug/vial	EUR 334

Anti-Galectin 1/LGALS1 Antibody
PB9240	BosterBio	100ug/vial	EUR 334

Anti-Galectin 1/Lgals1 Antibody
A00470	BosterBio	100ug/vial	EUR 334

Anti-Galectin 1 Biotinylated Antibody
A00470-Biotin	BosterBio	50ug/vial	EUR 294

Anti-galectin-1 (mouse) antibody
STJ72519	St John's Laboratory	100 µg	EUR 359

anti-Galectin 1 (1E8-1B2)
LF-MA10174	Abfrontier	100 ug	EUR 363
Description: Mouse monoclonal to Galectin 1

Anti-Galectin-13 (GAL13) / Placental Protein 13 (PP13) Monoclonal Antibody
M08143-1	BosterBio	100ug/vial	EUR 397
Description: Mouse Monoclonal Galectin-13 (GAL13) / Placental Protein 13 (PP13) Antibody. Validated in IHC and tested in Human.

anti-Galectin 3
YF-PA24079	Abfrontier	50 ul	EUR 334
Description: Mouse polyclonal to Galectin 3

anti-galectin 9
YF-PA24081	Abfrontier	50 ul	EUR 334
Description: Mouse polyclonal to galectin 9

anti-Galectin 3
YF-PA12946	Abfrontier	50 ug	EUR 363
Description: Mouse polyclonal to Galectin 3

anti-Galectin 3
YF-PA12947	Abfrontier	100 ul	EUR 403
Description: Rabbit polyclonal to Galectin 3

anti-Galectin 3
YF-PA12948	Abfrontier	100 ug	EUR 403
Description: Rabbit polyclonal to Galectin 3

anti-Galectin 8
YF-PA12951	Abfrontier	50 ul	EUR 363
Description: Mouse polyclonal to Galectin 8

anti-Galectin 13
YF-PA18585	Abfrontier	50 ug	EUR 363
Description: Mouse polyclonal to Galectin 13

Polyclonal Goat anti-GST μ-form
GST-ANTI-2	Detroit R&D	50 uL	EUR 280

Polyclonal Goat anti-GST p-form
GST-ANTI-3	Detroit R&D	50 uL	EUR 280

LGALS8 Human, Galectin-8 Human Recombinant Protein, His Tag
PROTO00214-1	BosterBio	Regular: 10ug	EUR 317
Description: LGALS8 Human Recombinant produced in E.Coli is a single, non-glycosylated, polypeptide chain containing 337 amino acids (1-317 a.a.) and having a molecular mass of 37.9 kDa. The LGALS8 is fused to a 20 amino acid His-Tag at N-terminus and purified by proprietary chromatographic techniques.

LGALS3 Human, Galectin-3 Human Recombinant Protein, His Tag
PROTP17931-1	BosterBio	Regular: 25ug	EUR 317
Description: LGALS3 Human Recombinant produced in E.Coli is a single, non-glycosylated, polypeptide chain containing 270 amino acids (1-250 a.a.) and having a molecular mass of 28.3 kDa._x000D_ The LGALS3 is fused to a 20 amino acid His-Tag at N-terminus and purified by proprietary chromatographic techniques. _x000D_

LGALS7 Human, Galectin-7 Human Recombinant Protein, His Tag
PROTP47929-1	BosterBio	Regular: 20ug	EUR 317
Description: Galectin-7 Human Recombinant fused with a 20 amino acid His tag at N-terminus produced in E.Coli is a single, non-glycosylated, polypeptide chain containing 156 amino acids (1-136 a.a.) and having a molecular mass of 17.2kDa. ;The Galectin-7 is purified by proprietary chromatographic techniques.

Anti-human Galectin-3 antibody
STJ15100163	St John's Laboratory	250 µg	EUR 336
Description: This monoclonal antibody is for studies of antigen expression in cells and tissue sections using immunocytochemistry and immunoprecipitation

Human Galectin-3 (Gal-3) AssayMax ELISA Kit
EG3311-1	AssayPro	96 Well Plate	EUR 477

Human Galectin-4 (Gal-4) AssayMax ELISA Kit
EG3312-1	AssayPro	96 Well Plate	EUR 477

Human Galectin 1 Protein
20-abx066725	Abbexa	EUR 620.00 EUR 272.00 EUR 1859.00 EUR 732.00 EUR 453.00	100 ug 10 ug 1 mg 200 ug 50 ug

Recombinant Human Galectin-1
7-00427	CHI Scientific	10µg	Ask for price

Recombinant Human Galectin-1
7-00428	CHI Scientific	50µg	Ask for price

Recombinant Human Galectin-1
7-00429	CHI Scientific	1mg	Ask for price

Human Galectin-1 (LGALS1)
1-CSB-EP012882HU	Cusabio	EUR 380.00 EUR 214.00 EUR 1309.00 EUR 560.00 EUR 873.00 EUR 262.00	100ug 10ug 1MG 200ug 500ug 50ug
Description: Recombinant Human Galectin-1(LGALS1) expressed in E.coli

Human Galectin-1 (LGALS1)
1-CSB-EP012882HUb1	Cusabio	EUR 380.00 EUR 214.00 EUR 1309.00 EUR 560.00 EUR 873.00 EUR 262.00	100ug 10ug 1MG 200ug 500ug 50ug
Description: Recombinant Human Galectin-1(LGALS1) expressed in E.coli

Galectin-1, human recombinant
4648-10	Biovision		EUR 142

Galectin-1, human recombinant
4648-1000	Biovision		EUR 1648

Galectin-1, human recombinant
4648-50	Biovision		EUR 262

Anti-Galectin-9 Antibody
A03415	BosterBio	100ul	EUR 397
Description: Rabbit Polyclonal Antibody for Galectin-9 Antibody (LGALS9) detection.tested for WB in Human, Mouse, Rat.

 

 

Bibliographic overview on the state-of-the-art of strontium and zinc primarily based regenerative therapies. Current developments and scientific purposes.

 

Musculoskeletal issues similar to osteoporosis and rheumatoid arthritis are chargeable for greater than 25ok deaths yearly within the European Union and represent a persistent burden on the people that suffer from this situation. There is no such thing as a medical remedy for these illnesses and there are various therapies utilized which have restricted effectiveness and extreme unwanted effects over time.

Regenerative therapies are being studied as a possible remedy for musculoskeletal illnesses and are recognized for his or her upgrading results of the pure therapeutic processes carried out within the human physique.

 

It’s believed that each strontium and zinc play a vital function in bone and cartilage tissue formation, which has led many scientists to review the impact of together with these components to advertise tissue formation and inhibit its resorption.

 

On this overview, a deep evaluation is undertaken of probably the most related developments in strontium and zinc primarily based regenerative therapies that have occurred within the final 5 years, taking into account solely these research reporting vital progress in direction of actual scientific purposes.

 

This overview brings updated the state-of-the-art of strontium and zinc primarily based regenerative therapies as it’s believed that each have a selling impact on tissue formation and have a vital function inhibiting resorption in musculoskeletal issues.

 

Handsearching had finest recall however poor effectivity when exporting to a bibliographic software: case examine.

 

To check the effectiveness and effectivity of strategies used to establish and export convention abstracts right into a bibliographic administration software.

Case examine. The effectiveness and effectivity of strategies to establish and export convention abstracts introduced on the American Society of Hematology (ASH) convention 2016-2018 for a scientific overview had been evaluated.

A reference customary handsearch of convention proceedings was in comparison with: 1) contacting Blood (the journal who report ASH proceedings); 2) key phrase looking out; 3) looking out Embase; 4) looking out MEDLINE through EndNote; and 5) looking out CPCI-S. Effectiveness was decided by the variety of abstracts recognized in contrast with the reference customary, whereas effectivity was a comparability between the sources required to establish and export convention abstracts in comparison with the reference customary.

604 probably eligible and 15 confirmed eligible convention abstracts (abstracts included within the overview) had been recognized by the handsearch. Comparator 2 was the one technique to establish all abstracts and it was extra environment friendly than the reference customary. Comparators 1, and 3-5 missed quite a lot of eligible abstracts.

This examine raises probably regarding questions on trying to find conferences’ abstracts by strategies aside from immediately looking out the unique convention proceedings. Effectivity of exporting could be improved if journals permitted bulk downloads.

 

Rabbit Anti-Influenza A HA (H3N2, 1-531aa/HA1+HA2) (A/Brisbane/10/2007) protein IgG, aff pure
H3N23-A	Alpha Diagnostics	100 ul	EUR 445

Influenza A H3 Antibody
abx021977-1mg	Abbexa	1 mg	EUR 878

Influenza A H3 Antibody
abx021978-1mg	Abbexa	1 mg	EUR 878

Influenza A Hemagglutinin H1 (A/Brisbane/59/2007)(H1N1) Peptide
11-563	ProSci	0.05 mg	EUR 527
Description: Influenza A Hemagglutinin H1 (A/Brisbane/59/2007)(H1N1) Peptide

Influenza A Hemagglutinin H1 (A/Brisbane/59/2007)(H1N1) Peptide
11-564	ProSci	0.05 mg	EUR 527
Description: Influenza A Hemagglutinin H1 (A/Brisbane/59/2007)(H1N1) Peptide

Influenza A antibody
10-1096	Fitzgerald	500 ug	EUR 208
Description: Mouse monoclonal Influenza A antibody

Influenza A antibody
10-1097	Fitzgerald	1 mg	EUR 349
Description: Mouse monoclonal Influenza A antibody

Influenza A antibody
10-1098	Fitzgerald	1 mg	EUR 605
Description: Mouse monoclonal Influenza A antibody

Influenza A antibody
10-1099	Fitzgerald	1 mg	EUR 605
Description: Mouse monoclonal Influenza A antibody

Influenza A antibody
10-1100	Fitzgerald	500 ug	EUR 349
Description: Mouse monoclonal Influenza A antibody

Influenza A antibody
10-1101	Fitzgerald	1 mg	EUR 605
Description: Mouse monoclonal Influenza A antibody

Influenza A antibody
10-1102	Fitzgerald	500 ug	EUR 349
Description: Mouse monoclonal Influenza A antibody

Influenza A antibody
10-1103	Fitzgerald	500 ug	EUR 349
Description: Mouse monoclonal Influenza A antibody

Influenza A antibody
10-1241	Fitzgerald	500 ug	EUR 349
Description: Mouse monoclonal Influenza A antibody

Influenza A antibody
10-1243	Fitzgerald	500 ug	EUR 349
Description: Mouse monoclonal Influenza A antibody

Influenza A antibody
10-7866	Fitzgerald	1 mg	EUR 403
Description: Mouse monoclonal Influenza A antibody

Influenza A antibody
10-7867	Fitzgerald	1 mg	EUR 403
Description: Mouse monoclonal Influenza A antibody

Influenza A antibody
10-I50A	Fitzgerald	1 mg	EUR 503
Description: Mouse monoclonal Influenza A antibody

Influenza A antibody
10-I50B	Fitzgerald	1 mg	EUR 392
Description: Mouse monoclonal Influenza A antibody

Influenza A antibody
10-I50C	Fitzgerald	1 mg	EUR 392
Description: Mouse monoclonal Influenza A antibody

Influenza A antibody
10-I50D	Fitzgerald	1 mg	EUR 279
Description: Mouse monoclonal Influenza A antibody

Influenza A antibody
10-I50E	Fitzgerald	1 mg	EUR 279
Description: Mouse monoclonal Influenza A antibody

Influenza A antibody
10-I50F	Fitzgerald	1 mg	EUR 273
Description: Mouse monoclonal Influenza A antibody

Influenza A antibody
10-I50G	Fitzgerald	1 mg	EUR 408
Description: Mouse monoclonal Influenza A antibody

Influenza A antibody
10-I50H	Fitzgerald	1 mg	EUR 541
Description: Mouse monoclonal Influenza A antibody

Influenza A antibody
10-I50I	Fitzgerald	1 mg	EUR 408
Description: Mouse monoclonal Influenza A antibody

Influenza A antibody
10-I50K	Fitzgerald	1 mg	EUR 273
Description: Mouse monoclonal Influenza A antibody

Influenza A antibody
10-I50L	Fitzgerald	1 mg	EUR 300
Description: Mouse monoclonal Influenza A antibody

Influenza A antibody
10-I50M	Fitzgerald	1 mg	EUR 300
Description: Mouse monoclonal Influenza A antibody

Influenza A antibody
10-I50N	Fitzgerald	1 mg	EUR 300
Description: Mouse monoclonal Influenza A antibody

Influenza A antibody
10-I50O	Fitzgerald	1 mg	EUR 300
Description: Mouse monoclonal Influenza A antibody

Influenza A antibody
10-I50P	Fitzgerald	1 mg	EUR 300
Description: Mouse monoclonal Influenza A antibody

Influenza A antibody
10-I50Q	Fitzgerald	1 mg	EUR 273
Description: Mouse monoclonal Influenza A antibody

Influenza A antibody
10-I50R	Fitzgerald	1 mg	EUR 273
Description: Mouse monoclonal Influenza A antibody

Influenza A antibody
10-I50S	Fitzgerald	1 mg	EUR 273
Description: Mouse monoclonal Influenza A antibody

Influenza A antibody
10-I50T	Fitzgerald	1 mg	EUR 273
Description: Mouse monoclonal Influenza A antibody

Influenza A antibody
10-I50U	Fitzgerald	1 mg	EUR 273
Description: Mouse monoclonal Influenza A antibody

Lung Tissue Lysate (Tumor)
1703-07	ProSci	0.1 mg	EUR 280.25
Description: Lung tumor tissue lysate was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 5% β-mercaptoethanol.

Kidney Tissue Lysate (Tumor)
1707-07	ProSci	0.1 mg	EUR 280.25
Description: Kidney tumor tissue lysate was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 5% β-mercaptoethanol.

Breast Tissue Lysate (Normal)
1710-07	ProSci	0.1 mg	EUR 217.25
Description: Breast tissue lysate was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 5% β-mercaptoethanol.